How to interpret the radiological abnormalities that persist after treatment in non-Hodgkin’s lymphoma patients?
Open Access
- 1 October 1999
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 10 (10), 1141-1143
- https://doi.org/10.1023/a:1008308129857
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's LymphomasJournal of Clinical Oncology, 1999
- Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.Journal of Clinical Oncology, 1997
- Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients.Journal of Clinical Oncology, 1997
- Monitoring Bulky Mediastinal Disease with Gallium-67, CT-Scan and Magnetic Resonance Imaging in Hodgkin's Disease and High-Grade Non-Hodgkin's LymphomaLeukemia & Lymphoma, 1996
- The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patientsSeminars in Nuclear Medicine, 1995
- Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.Radiology, 1994
- The Significance of Isolated Gallium-67 Uptake in the Hilar Lymph Nodes of an Untreated Lymphoma PatientClinical Nuclear Medicine, 1993
- Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma.Journal of Clinical Oncology, 1990
- High frequency of benign mediastinal uptake of gallium-67 after completion of chemotherapy in children with high-grade non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1989
- Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management.Journal of Clinical Oncology, 1988